Pharmacokinetic studies of green tea catechins in maternal plasma and fetuses in rats

Journal of Pharmaceutical Sciences

Volumn 95, Issue 6, 2006, Pages 1372-1381

  Chu, Kai On ^a   Wang, Chi Chiu ^a   Chu, Ching Yan ^a   Chan, Kwok Ping ^a   Rogers, Michael Scott ^a   Choy, Kwong Wai ^a   Pang, Chi Pui ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Catechins; Distribution; Pharmacokinetics; Placenta; Pregnancy; Tissue partition

Indexed keywords

CATECHIN; ENZYME; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EXPOSURE; ENZYME METABOLISM; FEMALE; FETUS; GESTATION PERIOD; MATERNAL PLASMA; NONHUMAN; PLACENTA; PREGNANCY; RAT; URINE;

EID: 33745026237     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.20594     Document Type: Article

References (40)

1. Ahmad N, Mukhtar H. 1999. Green tea polyphenols and cancer: Biologic mechanisms and practical implications. Nutr Rev 57:78-83.
2. Mitscher LA, Jung M, Shankel D, Dou JH, Steele L, Pilllai SP. 1997. Chemoprotection: A review of the potential therapeutic antioxidant properties of green tea (Camellia Sinensis) and certain of its constituents. Medic Res Rev 17:327-365.
3. Anghileri LJ, Thouvenot P. 2000. Natural polyphenols-iron interaction. Biologic Trace Element Res. 73:251-258.
4. Rietveld A, Wiseman S. 2003. Antioxidant effects of teal evidence from human clinical trials. J Nutri 133:3285S-3292S.
5. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Yun YP, Lee BM, Kim PY. 2001. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res 888: 11-18.
6. Thiagarajan G, Chandani S, Sundari CS, Rao SH., Kulkarni AV, Balasubramanian D. 2001. Antioxidant properties of green and black tea, and their potential ability to retard the progression of eye lens cataract. Exper Eye Res 73:393-401.
7. Cornish KM, Williamson G, Sanderson J. 2002. Quercetin metabolism in the lens: Role in inhibition of hydrogen peroxide induced cataract. Free Radix Biol Medic 33:63-70.
8. Saugstad OD. 1998. Oxygen radical disease in neonatology. Semin Neonatol 3:229-238.
9. Johnston MV, Trescher WH, Ishida A, Nakajima W. 2001. The developing nervous system: A series of review articles. Pediatric Res 49:735-741.
10. Rosenfeld WN, Davis JM. 1998. Prevention of oxygen radical disease in the newborn: Possible therapeutic approaches. Semin Neonatol 3:239-244.
11. Rice-Evans CA, Diplock AT. 1993. Current status of antioxidant therapy. Free Radic Biol Medic 15: 77-96.
12. Mochizuki M, Yamazaki S, Kano K, Ikeda T. 2002. Kinetic analysis and mechanistic aspects of autoxidation of catechin. Biochimica Biophysica Acta 1569:35-44.
13. Chan MMY, Fong D, Ho CT. Huang H. 1997. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. Biochem Pharmacol 54:1281-1286.
14. Lin JK, Liang YC, Shiau SYL. 1999. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem Pharmacol 58:911-915.
15. Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqq TM. 2002. Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1β-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Bio Medic 33:1097-1105.
16. Levites Y, Amit T, Youdim MBH, Manel S. 2002. Involvement of protein kinase c activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin-3-gallate neuroprotective action. J Biologic Chem 277:20574-20580.
17. Yang CS, Chen L, Lee MJ, Balentine D, Kuo MC, Schantz SP. 1998. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer epidemiol biomarkers prev 7:351-354.
18. Natsume M, Osakabe N, Oyama M, Sasaki M, Baba S, Nakamura Y, Osawa T, Terao J. 2003. Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: Differences between human and rat. Radic Biol Medic 34:840-849.
19. Piskula MK, Terao J. 1998. Accummulation of (-)-epicatechin metabolites in rat plasma after oral administration and distribution of conjugation enzymes in rat tissues. J Nutri 128:1172-1178.
20. Chu KO, Wang CC, Chu CY, Rogers MS, Choy KW, Pang CP. 2004. Determination of catechins and catechin gallates in biological fluid by HPLC with coulometric array detection and solid phase extraction. Analytic Chim Acta 510: 69-76.
21. Chu KO, Wang CC, Chu CY, Rogers MS, Choy KW, Pang CP. 2004. Method for determination of catechins and catechin gallates in tissues by HPLC with coulometric with coulometric array detection and selective solid phase extraction. J Chromatogr B 810:187-195.
22. Chow SHH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. 2001. Phase I Pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 10:53-58.
23. Birkett DJ, 1998. Non-linear pharmacokinetics. In: Birkett DJ, editor. Pharmacokinetics made easy. Roseville, Australia: McGraw-Hill Co., Inc., pp 77-78.
24. Gabrielsson J, Weiner D. 2000. PK40-Enterohepatic recirculation. In: Gabrielsson J, Weiner D, editor. Pharmacokinetic and pharmacodynamic data analysis: Concepts & applications. Stockholm, Sweden: Swedish Pharmaceutical Society, Swedish Pharmaceutical Press. pp 633-638.
25. Chen L, Lee MJ, Li H, Yang CS. 1997. Absorption, distribution and elimination of tea polyphenols in rats. Drug Metabol Dispos 25:1045-1049.
26. Nakagawa K, Miyazawa T. 1997. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J Nutri Sci Vitaminol 43:679-684.
27. Kim S, Lee MJ, Hong JG, Li C, Smith TJ, Yang GY, Seril DN, Yang CS. 2000. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutri Cancer 37:41-48.
28. Abd El Mohsen MM, Kuhnle G, Rechner AR, Schroeter H, Rose S, Jenner P, Rice-Evans CA. 2002. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 33:1693-1702.
29. Harada M, Kara Y, Naoki H. 1999. Identification of the major antioxidative metabolites in biological fluids of the rat with ingested (+)-catechin and (-)-epicatechin. Biosci Biotechnol Biochem 63:973-977.
30. Kida K, Suzuki M, Matsumoto N, Nanjo F, Hara Y. 2000. Identification of biliary metabolites of (-)-epigallocatechin gallate in rats. J Agric Food Chem 48:4151-4155.
31. Cai Y, Anavy ND, Chow HS. 2002. Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metabol Disp 30:1246-1249.
32. Hong L, Meng XF, Li C, Sang SM, Patten C, Sheng SQ, Hong JG, Bai NS, Winnik B, Ho CT, Yang CS. 2003. Glucuronides of tea catechins: Enzymology of biosynthesis and biological activities. Drug Metabol Disp 31:452-461.
33. Takizawa Y, Morota T, Takeda S, Aburada M. 2003. Pharmacokinetics of (-)-Epicatechin-3-o-gallate, an active component of Onpi-to, in rats. Biologic Pharmaceut Bull 26:608-612.
34. Lee MJ, Lambert JD, Prabhu S, Meng XF, Lu H, Maliakal P, Ho CT, Yang CS. 2004. Delivery of tea polyphenols to the oral cavity by green tea leaves and black tea extract. Cancer epidemiol biomarkers Prev 13:132-137.
35. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3-26.
36. Unadkat JD, Kahlin A, Vijay S. 2004. Placental drug transporters. Curr Drug Metabol 5:125-131.
37. Morgan JD. 1997. Drug disposition in mother and foetus. Clin Exper Pharmcol Physiol 24:869-873.
38. Lambert JD, Yang CS. 2003. Mechanism of cancer prevention by tea constituents. J Nutr 133:3262S-3267S.
39. Stanwood GD, Levitt P. 2004. Drug exposure early in life: Functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 4:65-71.
40. Zhu BT, Patel UK, Cai MX, Conney AH. 2000. O-methylation of tea polyphenols catalyzed by human placental cytosolic catechol-o-methyltransferase. Drug Metab Dispos 28:1024-1030.